The role of IL-18 in the pathogenesis of systemic lupus erythematosus is still not definitively solved. In this study, we generated MRL lpr mice, which develop a disease resembling systemic lupus erythematosus, genetically devoid of IL-18 expression. These mice in comparison to IL-18-competent MRL lpr mice show reduced signs of renal pathogenesis, while other parameters such as mean survival time, lymphadenopathy, constitutive interferon-γ production, and frequency of CD3 + B220 + abnormal T cells were without differences. We conclude that in the systemic lupus erythematosus syndrom IL-18 is involved specifically in the renal pathogenesis.
Introduction
The interleukin (IL)-1 family member IL-18, originally referred to as 'interferon (IFN)-γ-inducing factor (IGIF)', is a proinflammatory cytokine [1] . Major cellular targets of IL-18 are T helper (Th) 1 cells, natural killer (NK) cells, and CD8 + T cells, in which it increases proliferation, lytic activity and IFNγ production [2] [3] [4] . IL-18 by itself does not induce IFN-γ expression, but rather acts synergistically with e.g. IL-12, which induces expression of the IL-18 receptor [5, 6] . The participation of IL-18 in inflammatory diseases including autoimmunity has been demonstrated in several animal models and also in humans [7] [8] [9] . Of those, the predominant ones are type 1 diabetes, multiple sclerosis, rheumatoid arthritis, psoriasis, and possibly also systemic lupus erythematosus (SLE). SLE is characterized by hyper-gammaglobulinemia, autoantibody production and immune complex formation, eventually leading to end-organ damage, including vasculitis and fatal renal failure [10] . The disease is associated with genetic polymorphisms in the il18 gene in diverse populations [11] [12] [13] . In plasma of SLE patients the concentration of IL-18 is enhanced and correlates with the disease activity [14] [15] [16] .
Homozygous MRL/Mp-Tnfrsf6 lpr/lpr (MRL lpr ) mice serve as model for human SLE [17] . Thcells, characterized by the expression of CD4, centrally contribute to the pathogenesis of MRL lpr mice [18] . Of those, IL-17-expressing cells constitute a decisive effector population [19] ; however, also Th1-and Th2-derived cytokines are apparently involved: IFN-γ, the prototypical Th1-cytokine, is detected at rather high concentrations in serum of MRL lpr mice and deletion of IFN-γ or IFN-γ receptor expression leads to reduced pathological signs [20] [21] [22] [23] . In accordance with these observations, administration of IFN-γ exacerbates the disease [24] . [26] . Genetic deletion of the IL-18 receptor in MRL lpr mice has been described in two independent studies with contradictory conclusions [29, 30] . While the first one claimed the amelioration of the lupus-like disease due to the absence of the IL-18 receptor expression [30] , the second one could not find any consequences of the deletion [29] . 
Serum preparation
The blood obtained by exsanguination was clotted for either one hour at room temperature or overnight at 4°C. Serum was separated by centrifugation at 10,000 g, 4°C for 20 min, aliquoted and stored at-80°C until use.
Organ and cell preparation
Axillary and inguinal lymph nodes, spleens, and kidneys were removed and dissociated into single cell suspensions using the gentleMACS dissociator system (Miltenyi Biotech, Bergisch Gladbach, Germany).
Lymphadenopathy and splenomegaly
Lymphocyte proliferation in lymph nodes and spleen was assessed in parallel with two methods. Weights of lymph nodes and spleens were evaluated routinely to assess the macroscopic lymphadenopathy. In addition, nucleated cell counts were performed after organ dissociation.
Proteinuria
Urine protein levels were assessed semi-quantitatively using Combur Test strips (BoehringerMannheim, Mannheim, Germany). Small volumes (20 μl) of spontaneously voided urine were taken at weekly intervals.
Determination of renal damage
Renal tissue was either fixed in formalin and embedded in paraffin or was prepared for cryoconservation. Sections were stained with hematoxylin and eosin (H&E), periodic acid-Schiff (PAS), or silver based reticulin. Kidney lesions were scored according to Table 2 , analyzing at least 2 sections of each kidney and 55 +/-5 glomeruli of each section.
Statistical analysis
Where appropriate, data are presented as individual values and the mean ± SD. Statistical significance was determined using Student's t test or one-or two-way ANOVA with Bonferroni's post-test. Proteinuria data were analyzed by Kruskal-Wallis test with Dunn's post-test, whereas survival analysis was performed using Kaplan-Meier method and significance of differences in survival was determined using Mantle-Cox and Gehan-Breslow-Wilcoxon tests.
Results
In order to analyze a possible role of IL-18 in the pathogenesis of the lupus-like disease in MRL/Mp-Tnfrs6lpr IL-18, which promotes IFN-γ production [5] is constitutively expressed in e.g. macrophages and dendritic cells. Thus, we measured constitutive IFN-γ concentrations in sera, but, again, could not detect statistically significant differences depending on the IL-18 genotype (Fig 2) . Differences were also absent when comparing age-matched subgroups of mice (not shown).
The lupus-like disease in MRL lpr mice is paralleled by the persistence of CD3 + B220 concentrations in urine increased as fast as in MRL lpr mice. In MRL lpr IL18 tm/tm mice, in contrast, the kinetics of proteinuria development were significantly slower, virtually resembling that observed in MRL +/+ mice (Fig 4) .
Next, we evaluated the kidneys histologically, both by light (Fig 5A) and by electron microscopy (data not shown (Fig 5B) .
Discussion
Several studies point to a contribution of IL-18 to symptoms associated with human lupus and the lupus-like disease in mouse models [7, [35] [36] [37] [38] . In the MRL lpr mouse model resembling human SLE such evidence based on a genomic approach is discussed very controversially [29, 30] . These studies, in order to eliminate IL-18 bioactivity, deleted the IL-18 receptor, but more recently it has also been reported that the IL-18 receptor is necessary not only for IL-18 bioactivity but also for a yet not identified ligand [31] , probably similar to the human IL-18 receptor ligand IL-37 [39] . Thus, in order to specifically analyze the function of IL-18 in murine SLE, in In MRL lpr mice serum concentrations of IFN-γ are enhanced in comparison to not autoimmune-prone mouse strains and IFN signaling is essential for lupus development [20] [21] [22] [23] .
Blockade of IFN-γ signaling by deleting expression of the cytokine itself or its receptor results in reduced double-stranded DNA-directed autoantibody production and prolonged survival. Interestingly, lymphadenopathy and the number of DN T-cells are reduced in MRL lpr only due to IFN-γ-deficiency, while it is unaffected by the lack of the IFN-γ receptor. IL-18 promotes IFN-γ expression in T-cells and NK cells [1] , however, since IL-18-deficiency in MRL lpr mice does not reduce IFN-γ concentration in blood, the constitutively enhanced production of IFN-γ is not a consequence of IL-18 function [25] . Probably due to the unaffected IFN-γ concentration, IL-18 deficiency in MRL lpr mice affects neither survival nor the accumulation of DN Tcells accompanied by lymphadenopathy and splenomegaly. These data are in contrast to our previous ones obtained by a cDNA vaccination technique [27] , probably reflecting that vaccination of MRL lpr mice with an IL18-encoding plasmid not only led to the reduction of IL-18 bioactivity but also to additional beneficial effects, e.g. TLR9 activation [40, 41] , leading to an amelioration of clinical parameters. Thus, the effect of IL-18 in MRL lpr mice seems to be restricted to the kidney inflammation and probably other organs as well, which we have not analyzed in this study. Such a specific function for IL-18 in autoimmune lupus nephritis as well as in other kidney diseases already has been proposed previously [39, [42] [43] [44] . Interestingly, deletion of IL-18 expression in MRL lpr mice selectively reduced the intra-renal frequency of T-cells, both CD4 + and CD8 + , while other leukocyte populations, such as granulocytes, monocytes, and macrophages were unaffected. This is in contrast to data provided by an 'intra-renal IL-18 overexpression' model [43] , and may reflect an IL-18 concentration exceeding the physiologic range in the latter study. , CD4 + , and CD8 + cells within the CD45 + population were determined. Presented are data of individual evaluations and the respective means +/-SD. The data sets (n = 9 and 13, respectively) were analysed by Student's T-test and revealed no statistically significant differences. Surprisingly, the fast worsening general health status, quantified as 'survival', is unaffected by deletion of IL-18 expression, although specific parameters of nephritis are ameliorated. This may be due to the fact that only a few specific kidney pathological parameters were reduced due to IL-18 deletion, while others and also the gross inflammatory pathology remained unaffected.
In summary, using a genetic approach, we provide evidence that IL-18 plays a minor role in the autoimmune disease in MRL lpr mice, essentially confirming the data observed in IL-18-deficient lupus-prone C57Bl/6 mice [45] . In our model, IL-18 does not affect the lupus-like pathogenesis generally, but specifically some parameters of affected end-organs, i.e. the kidneys. 
